Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.80% Nasdaq Up0.97%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS

64.01 Down 0.49(0.76%) May 17, 4:00PM EDT|After Hours : 64.00 Down 0.01 (0.02%) May 17, 5:30PM EDT

Add to Portfolio
Key StatisticsGet Key Statistics for:
Data provided by Capital IQ, except where noted.
Valuation Measures 
Market Cap (intraday)5:8.90B
Enterprise Value (May 20, 2013)3:8.61B
Trailing P/E (ttm, intraday):N/A
Forward P/E (fye Dec 31, 2014)1:N/A
PEG Ratio (5 yr expected)1:-1.47
Price/Sales (ttm):17.51
Price/Book (mrq):7.17
Enterprise Value/Revenue (ttm)3:16.81
Enterprise Value/EBITDA (ttm)6:-132.06
Financial Highlights 
Fiscal Year
Fiscal Year Ends:Dec 30
Most Recent Quarter (mrq):Mar 31, 2013
Profitability
Profit Margin (ttm):-25.43%
Operating Margin (ttm):-20.03%
Management Effectiveness
Return on Assets (ttm):-4.43%
Return on Equity (ttm):-12.88%
Income Statement
Revenue (ttm):512.00M
Revenue Per Share (ttm):4.15
Qtrly Revenue Growth (yoy):9.70%
Gross Profit (ttm):408.89M
EBITDA (ttm)6:-65.17M
Net Income Avl to Common (ttm):-130.18M
Diluted EPS (ttm):-1.05
Qtrly Earnings Growth (yoy):N/A
Balance Sheet
Total Cash (mrq):401.88M
Total Cash Per Share (mrq):2.89
Total Debt (mrq):109.85M
Total Debt/Equity (mrq):8.79
Current Ratio (mrq):5.02
Book Value Per Share (mrq):9.00
Cash Flow Statement
Operating Cash Flow (ttm):-7.25M
Levered Free Cash Flow (ttm):-26.26M
View Financials
Income Statement - Balance Sheet - Cash Flow

Trading Information 
Stock Price History
Beta:0.76
52-Week Change3:69.79%
S&P500 52-Week Change3:28.74%
52-Week High (May 14, 2013)3:71.56
52-Week Low (Jun 1, 2012)3:34.30
50-Day Moving Average3:64.50
200-Day Moving Average3:55.92
Share Statistics
Avg Vol (3 month)3:1,304,260
Avg Vol (10 day)3:1,499,780
Shares Outstanding5:139.01M
Float:138.59M
% Held by Insiders1:0.28%
% Held by Institutions1:110.90%
Shares Short (as of Apr 30, 2013)3:4.02M
Short Ratio (as of Apr 30, 2013)3:3.60
Short % of Float (as of Apr 30, 2013)3:4.40%
Shares Short (prior month)3:4.19M
Dividends & Splits
Forward Annual Dividend Rate4:N/A
Forward Annual Dividend Yield4:N/A
Trailing Annual Dividend Yield3:N/A
Trailing Annual Dividend Yield3:N/A
5 Year Average Dividend Yield4:N/A
Payout Ratio4:N/A
Dividend Date3:N/A
Ex-Dividend Date4:N/A
Last Split Factor (new per old)2:N/A
Last Split Date3:N/A

See Key Statistics Help for definitions of terms used.
Abbreviation Guide: K = Thousands; M = Millions; B = Billions
mrq = Most Recent Quarter (as of Mar 31, 2013)
ttm = Trailing Twelve Months (as of Mar 31, 2013)
yoy = Year Over Year (as of Mar 31, 2013)
lfy = Last Fiscal Year (as of Dec 31, 2012)
fye = Fiscal Year Ending
1 Data provided by Thomson Reuters
2 Data provided by EDGAR Online
3 Data derived from multiple sources or calculated by Yahoo! Finance
4 Data provided by Morningstar, Inc.
5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
6 EBITDA is calculated by Capital IQ using methodology that may differ from that used by a company in its reporting

Currency in USD.